MERS Cov vaccine (Barinthus)

N/A

Report date: 2025/04/14 14:32:40

Base Information

Drug NameMERS Cov vaccine (Barinthus)
Drug Alias NameMERS-CoV vaccine – VaccitechMiddle East respiratory syndrome coronavirus vaccine - VaccitechMERS vaccine - VaccitechChAdOx1 MERS vaccineChAdOx1 MERS +[6] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMiddle East Respiratory Syndrome CoronavirusCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySaudi ArabiaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Jenner InstituteBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesBarinthus Biotherapeutics PLC
Inactive CompaniesUniversity Of Oxford
Active IndicationsCoronavirus Infections
Inactive IndicationsMiddle East Respiratory Syndrome Coronavirus

Other Information

ATC CodeN/A
Related LinksN/A